Health Care [ 5/12 ] | Biotechnology [ 51/74 ]
NASDAQ | Common Stock
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines.
Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct.
The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia.
Benitec Biopharma Inc. is headquartered in Hayward, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 14, 26 | -0.24 Increased by 0.00% | -0.28 Increased by +14.29% |
| Feb 12, 26 | -0.26 Increased by +21.21% | -0.23 Decreased by -13.04% |
| Nov 14, 25 | -0.22 Increased by +54.17% | -76.32 Increased by +99.71% |
| Sep 22, 25 | -0.42 Increased by +68.18% | -0.31 Decreased by -35.48% |
| May 14, 25 | -0.24 Increased by +85.37% | -0.35 Increased by +31.43% |
| Feb 14, 25 | -0.33 Increased by +87.50% | -0.78 Increased by +57.69% |
| Nov 14, 24 | -0.48 Increased by +82.61% | -0.55 Increased by +12.73% |
| Sep 19, 24 | -1.32 Increased by +53.36% | -0.49 Decreased by -169.39% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 0.00 Decreased by N/A% | -11.94 M Increased by +17.70% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 25 | 0.00 Decreased by N/A% | -11.84 M Decreased by -23.92% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -8.96 M Decreased by -77.21% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 556.00 K Increased by +9.37 K% | -16.15 M Decreased by -242.10% | Decreased by -2.90 K% Decreased by -103.69% |
| Mar 31, 25 | 0.00 Decreased by -100.00% | -14.50 M Decreased by -238.89% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -9.55 M Decreased by -40.51% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -5.06 M Increased by +15.03% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | -6.00 K Decreased by -185.71% | -4.72 M Decreased by -1.27% | Increased by +78.67 K% Increased by +218.14% |